vs

Side-by-side financial comparison of BLACKBERRY Ltd (BB) and Inspire Medical Systems, Inc. (INSP). Click either name above to swap in a different company.

Inspire Medical Systems, Inc. is the larger business by last-quarter revenue ($269.1M vs $141.8M, roughly 1.9× BLACKBERRY Ltd). Inspire Medical Systems, Inc. runs the higher net margin — 50.6% vs 9.7%, a 40.9% gap on every dollar of revenue. On growth, Inspire Medical Systems, Inc. posted the faster year-over-year revenue change (12.2% vs -0.8%). Inspire Medical Systems, Inc. produced more free cash flow last quarter ($41.8M vs $17.4M). Over the past eight quarters, Inspire Medical Systems, Inc.'s revenue compounded faster (28.1% CAGR vs 17.8%).

BlackBerry Limited, formerly Research In Motion (RIM), is a Canadian software company specializing in secure communications and the Internet of Things (IoT). Founded in 1984, it developed the BlackBerry brand of two-way pagers, smartphones, and tablets. The company later transitioned to providing software and services and holds critical software application patents.

Inspire Medical Systems, Inc. is a medical technology firm that develops, manufactures and commercializes implantable neurostimulation solutions for obstructive sleep apnea. Its core product serves patients intolerant to CPAP therapy, with main markets across North America, Europe, and select Asia-Pacific regions, operating in sleep medicine and otolaryngology segments.

BB vs INSP — Head-to-Head

Bigger by revenue
INSP
INSP
1.9× larger
INSP
$269.1M
$141.8M
BB
Growing faster (revenue YoY)
INSP
INSP
+13.1% gap
INSP
12.2%
-0.8%
BB
Higher net margin
INSP
INSP
40.9% more per $
INSP
50.6%
9.7%
BB
More free cash flow
INSP
INSP
$24.4M more FCF
INSP
$41.8M
$17.4M
BB
Faster 2-yr revenue CAGR
INSP
INSP
Annualised
INSP
28.1%
17.8%
BB

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
BB
BB
INSP
INSP
Revenue
$141.8M
$269.1M
Net Profit
$13.7M
$136.1M
Gross Margin
77.5%
86.6%
Operating Margin
8.4%
17.1%
Net Margin
9.7%
50.6%
Revenue YoY
-0.8%
12.2%
Net Profit YoY
224.5%
286.4%
EPS (diluted)
$0.02
$4.57

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BB
BB
INSP
INSP
Q4 25
$141.8M
$269.1M
Q3 25
$129.6M
$224.5M
Q2 25
$121.7M
$217.1M
Q1 25
$141.7M
$201.3M
Q4 24
$143.6M
$239.7M
Q3 24
$126.2M
$203.2M
Q2 24
$123.4M
$195.9M
Q1 24
$102.1M
$164.0M
Net Profit
BB
BB
INSP
INSP
Q4 25
$13.7M
$136.1M
Q3 25
$13.3M
$9.9M
Q2 25
$1.9M
$-3.6M
Q1 25
$-7.4M
$3.0M
Q4 24
$-10.5M
$35.2M
Q3 24
$-19.7M
$18.5M
Q2 24
$-41.4M
$9.8M
Q1 24
$-56.2M
$-10.0M
Gross Margin
BB
BB
INSP
INSP
Q4 25
77.5%
86.6%
Q3 25
74.5%
85.8%
Q2 25
74.2%
84.0%
Q1 25
73.5%
84.7%
Q4 24
78.1%
85.0%
Q3 24
70.2%
84.1%
Q2 24
72.9%
84.8%
Q1 24
84.9%
Operating Margin
BB
BB
INSP
INSP
Q4 25
8.4%
17.1%
Q3 25
8.9%
4.3%
Q2 25
1.6%
-1.5%
Q1 25
-5.6%
-0.7%
Q4 24
13.6%
13.3%
Q3 24
1.7%
7.0%
Q2 24
-10.5%
2.6%
Q1 24
50.0%
-9.3%
Net Margin
BB
BB
INSP
INSP
Q4 25
9.7%
50.6%
Q3 25
10.3%
4.4%
Q2 25
1.6%
-1.7%
Q1 25
-5.2%
1.5%
Q4 24
-7.3%
14.7%
Q3 24
-15.6%
9.1%
Q2 24
-33.5%
5.0%
Q1 24
-55.0%
-6.1%
EPS (diluted)
BB
BB
INSP
INSP
Q4 25
$0.02
$4.57
Q3 25
$0.02
$0.34
Q2 25
$0.00
$-0.12
Q1 25
$-0.01
$0.10
Q4 24
$-0.02
$1.17
Q3 24
$-0.03
$0.60
Q2 24
$-0.07
$0.32
Q1 24
$-0.08
$-0.34

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BB
BB
INSP
INSP
Cash + ST InvestmentsLiquidity on hand
$304.2M
$308.3M
Total DebtLower is stronger
$196.2M
Stockholders' EquityBook value
$741.1M
$781.2M
Total Assets
$1.2B
$907.3M
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BB
BB
INSP
INSP
Q4 25
$304.2M
$308.3M
Q3 25
$290.5M
$322.6M
Q2 25
$306.6M
$300.9M
Q1 25
$337.8M
$369.2M
Q4 24
$220.0M
$445.5M
Q3 24
$211.0M
$411.0M
Q2 24
$229.0M
$439.7M
Q1 24
$237.1M
$441.4M
Total Debt
BB
BB
INSP
INSP
Q4 25
$196.2M
Q3 25
$195.9M
Q2 25
$195.6M
Q1 25
$195.3M
Q4 24
Q3 24
Q2 24
Q1 24
$194.1M
Stockholders' Equity
BB
BB
INSP
INSP
Q4 25
$741.1M
$781.2M
Q3 25
$725.1M
$666.5M
Q2 25
$725.1M
$677.8M
Q1 25
$719.9M
$635.7M
Q4 24
$725.2M
$689.7M
Q3 24
$732.1M
$696.6M
Q2 24
$742.6M
$638.1M
Q1 24
$775.1M
$589.0M
Total Assets
BB
BB
INSP
INSP
Q4 25
$1.2B
$907.3M
Q3 25
$1.2B
$807.7M
Q2 25
$1.2B
$802.2M
Q1 25
$1.3B
$730.8M
Q4 24
$1.3B
$808.4M
Q3 24
$1.3B
$796.2M
Q2 24
$1.3B
$728.4M
Q1 24
$1.4B
$685.8M
Debt / Equity
BB
BB
INSP
INSP
Q4 25
0.26×
Q3 25
0.27×
Q2 25
0.27×
Q1 25
0.27×
Q4 24
Q3 24
Q2 24
Q1 24
0.25×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BB
BB
INSP
INSP
Operating Cash FlowLast quarter
$18.3M
$52.5M
Free Cash FlowOCF − Capex
$17.4M
$41.8M
FCF MarginFCF / Revenue
12.3%
15.5%
Capex IntensityCapex / Revenue
0.6%
4.0%
Cash ConversionOCF / Net Profit
1.34×
0.39×
TTM Free Cash FlowTrailing 4 quarters
$42.8M
$78.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BB
BB
INSP
INSP
Q4 25
$18.3M
$52.5M
Q3 25
$3.9M
$68.5M
Q2 25
$-18.0M
$2.7M
Q1 25
$41.6M
$-6.7M
Q4 24
$6.0M
$69.2M
Q3 24
$-16.0M
$52.3M
Q2 24
$-15.1M
$-78.0K
Q1 24
$-15.5M
$8.9M
Free Cash Flow
BB
BB
INSP
INSP
Q4 25
$17.4M
$41.8M
Q3 25
$3.1M
$58.1M
Q2 25
$-18.9M
$-6.3M
Q1 25
$41.2M
$-15.1M
Q4 24
$5.2M
$62.2M
Q3 24
$-16.5M
$44.3M
Q2 24
$-16.5M
$-12.5M
Q1 24
$-17.6M
$-2.8M
FCF Margin
BB
BB
INSP
INSP
Q4 25
12.3%
15.5%
Q3 25
2.4%
25.9%
Q2 25
-15.5%
-2.9%
Q1 25
29.1%
-7.5%
Q4 24
3.6%
25.9%
Q3 24
-13.1%
21.8%
Q2 24
-13.4%
-6.4%
Q1 24
-17.2%
-1.7%
Capex Intensity
BB
BB
INSP
INSP
Q4 25
0.6%
4.0%
Q3 25
0.6%
4.6%
Q2 25
0.7%
4.1%
Q1 25
0.3%
4.2%
Q4 24
0.6%
2.9%
Q3 24
0.4%
3.9%
Q2 24
1.1%
6.3%
Q1 24
2.1%
7.1%
Cash Conversion
BB
BB
INSP
INSP
Q4 25
1.34×
0.39×
Q3 25
0.29×
6.90×
Q2 25
-9.47×
Q1 25
-2.24×
Q4 24
1.96×
Q3 24
2.83×
Q2 24
-0.01×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BB
BB

QNX$68.7M48%
Secure Communication$67.0M47%
Licensing$6.1M4%

INSP
INSP

Segment breakdown not available.

Related Comparisons